pharma · Scabies · Bioequivalence trial in healthy volunteers
Alphapharm
Alphapharm Pty Ltd
Alphapharm clinical programs — 7 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Level 1, 30 The Bond, 30-34 Hickson Road, Millers Point, NSW 2000, AU
- Founded
- 1982
- Employees
- 187
- Programs
- 30
- Drugs
- 235
- Patents
- 12
Alphapharm projects
7 ClinicalTrials.gov programs sponsored by Alphapharm.
Alphapharm has 7 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
CR6086-1-04
Alphapharm Pty Ltd
Pretreated mismatch-repair-proficient and microsatellite stable metastatic colorectal cancer, and other metastatic GI cancers
1 trial -
Debio 4228, Debio 4228
Alphapharm Pty Ltd
advanced prostate cancer
1 trial -
HM-GCG-201
Alphapharm Pty Ltd
Congenital Hyperinsulinism (CHI)
1 trial -
PTT101
Alphapharm Pty Ltd
Central nervous system (CNS) lymphoma; recurrent or refractory primary or isolated secondary
1 trial -
Radotinib HCl, Placebo for Radotinib HCl
Alphapharm Pty Ltd
Treatment of Parkinson’s disease (PD)
1 trial -
Solution for injection in pre-filled syringe
Alphapharm Pty Ltd
Short Bowel Syndrome-associated Intestinal Failure (SBS-IF)
1 trial -
WSD0922-FU, WSD0922-FU
Alphapharm Pty Ltd
Non-Small Cell Lung Cancer
1 trial
Frequently asked questions
How many clinical projects does Alphapharm have?
7 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.